Company Data
LadRx Corp
Ticker
LADX
Current Price
$1.77 -8.76%
Market Cap
$876.3K
Price Target
Refer to Report
Volume
536
52wk Range
$0.4621 - $3.5
Overview
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.